Esophageal Dysphagia Market Report 2026

The esophageal dysphagia market size has grown strongly in recent years. It will grow from $2.19 billion in 2025 to $2.32 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to aging population, gastroesophageal disorders, diagnostic endoscopy growth, hospital gi care expansion, swallowing disorder awareness.

The esophageal dysphagia market size is expected to see strong growth in the next few years. It will grow to $3.08 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to early diagnosis adoption, minimally invasive therapy innovation, outpatient treatment growth, advanced imaging availability, multidisciplinary care models. Major trends in the forecast period include growing demand for minimally invasive treatment, increased use of esophageal dilation procedures, expansion of advanced diagnostic techniques, rising focus on swallowing disorder management, emphasis on patient-centered care.

The rising number of strokes is expected to drive the growth of the esophageal dysphagia market going forward. A stroke occurs when a blood vessel in the brain ruptures or when blood flow to a specific part of the brain is blocked. Strokes can impact the brain regions responsible for swallowing, potentially leading to esophageal dysphagia. For instance, in May 2023, Medical Xpress, a US-based online medical and health news platform, reported that global stroke-related deaths are projected to reach nearly 5 million by 2030. Therefore, the increasing incidence of strokes is fueling the growth of the esophageal dysphagia market.

Major companies in the esophageal dysphagia market are focusing on technological innovations, such as impedance planimetry-based measurement systems, to improve esophageal motility assessment, optimize treatment strategies, and enhance patient outcomes. An impedance planimetry system measures real-time pressure and cross-sectional area of the esophagus, enabling clinicians to assess esophageal distensibility and motility disorders, which are major contributors to dysphagia, providing higher spatial resolution than traditional manometry tests. For instance, in November 2024, Medtronic, a US-based medical device company, launched the EndoFLIP 300 system. This product offers real-time, multi-point measurements of the esophagus using a balloon catheter with embedded impedance sensors, aiding the diagnosis of esophageal motility disorders such as achalasia, esophagogastric junction (EGJ) outflow obstruction, and other conditions affecting swallowing, allowing for more precise treatment decisions and improved clinical outcomes.

In May 2023, Patheous Health Inc., a US-based company specializing in dysphagia care, acquired Carolina Speech Pathology LLC for an undisclosed amount. Through this acquisition, Patheous Health Inc. aims to expand its service network, offerings, and talent, strengthening its competitive position in the dysphagia healthcare market. Carolina Speech Pathology LLC is a US-based developer of mobile dysphagia swallow imaging devices designed to enhance the treatment of esophageal dysphagia.

Major companies operating in the esophageal dysphagia market are Nestle Health Science S.A., Fresenius Kabi AG, Abbott Laboratories, Danone S.A., Ingredion Incorporated, Olympus Corporation, Cook Medical Incorporated, Johnson and Johnson Ltd., C.R. Bard Inc., Avanos Medical Inc., Kent Precision Foods Group Inc., Nutricia Ltd., Atos Medical AB, NinePoint Medical Inc., Torax Medical Inc., Hormel Health Labs Inc., Dysphagia Management Systems LLC, Biostage Inc., Boston Scientific Corporation, Medtronic plc, Becton Dickinson and Company, Merit Medical Systems Inc., CONMED Corporation, EndoGastric Solutions Inc.

North America was the largest region in the esophageal dysphagia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the esophageal dysphagia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the esophageal dysphagia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the esophageal dysphagia market by increasing costs of imported endoscopic devices, diagnostic imaging tools, and stent systems. Hospitals and ambulatory surgical centers in developed regions are most affected due to reliance on imported equipment. These tariffs raise procedure costs by increasing device acquisition and maintenance expenses, impacting affordability of minimally invasive interventions. However, they support local manufacturing of GI devices, strengthening regional production of endoscopes, stents, and accessories.

The esophageal dysphagia market research report is one of a series of new reports that provides esophageal dysphagia market statistics, including esophageal dysphagia industry global market size, regional shares, competitors with a esophageal dysphagia market share, detailed esophageal dysphagia market segments, market trends and opportunities, and any further data you may need to thrive in the esophageal dysphagia industry. This esophageal dysphagia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Esophageal dysphagia is a medical condition characterized by difficulty swallowing solid or liquid foods due to structural or functional abnormalities of the esophagus, lower esophageal sphincter (LES), or cardia. It can result from various underlying conditions that disrupt normal esophageal function or impede the smooth passage of food and liquids.

The main treatments for esophageal dysphagia include esophageal dilation, surgery, stent placement, laparoscopic Heller myotomy, medications, and lifestyle modifications. Esophageal dilation is a medical procedure used to widen a narrowed or constricted section of the esophagus and is commonly employed to manage dysphagia caused by esophageal strictures. Diagnosis can involve dynamic swallowing studies, X-rays, endoscopy, manometry, imaging scans, magnetic resonance imaging (MRI), and computed tomography (CT) scans. The treatments are utilized by end users such as hospitals and clinics, ambulatory surgical centers, diagnostic centers, research centers, and others.

The esophageal dysphagia market consists of revenues earned by entities by providing services such as surgical assistance and physical therapy, clinical evaluation, impedance testing, dietary counseling and surgical interventions. The market value includes the value of related goods sold by the service provider or included within the service offering. The esophageal dysphagia market also includes the sales of feeding tubes, nasogastric tubes, nutritional solutions, thickeners, beverages, purees, dysphagia diets, esophageal dilation devices, surgical instruments, esophageal pH monitors, corticosteroids, antacids, proton-pump inhibitors (PPIs) and muscle relaxants. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.